| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, General Counsel, Corp Sec | EVP And General Counsel
1 company
De Verneuil Vanina is an EVP, General Counsel, Corp Sec at Vir Biotechnology, Inc.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $731K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | VIR Vir Biotechnology, Inc. | EVP, General Counsel, Corp Sec | Sell | 2,385 | $5.16 | $12,306.60 | -3.0% | +42.2% | - | |
| Nov 3, 2025 | VIR Vir Biotechnology, Inc. | EVP And General Counsel | Sell | 1,365 | $5.86 | $8,003.00 | -1.7% | +37.7% | - | |
| Feb 26, 2025 | VIR Vir Biotechnology, Inc. | EVP And General Counsel | Sell | 7,373 | $9.14 | $67,402.49 | -8.5% | -49.3% | +1.2% | |
| Feb 24, 2025 | VIR Vir Biotechnology, Inc. | EVP And General Counsel | Sell | 5,140 | $9.45 | $48,590.48 | -5.6% | -50.8% | +0.2% | |
| Dec 2, 2024 | VIR Vir Biotechnology, Inc. | EVP And General Counsel | Sell | 76 | $8.22 | $624.73 | -0.1% | -2.8% | -30.9% | |
| Nov 6, 2024 | VIR Vir Biotechnology, Inc. | EVP And General Counsel | Sell | 4,397 | $10.11 | $44,453.67 | -7.2% | -4.7% | -49.7% | |
| Nov 5, 2024 | VIR Vir Biotechnology, Inc. | EVP And General Counsel | Sell | 3,750 | $8.62 | $32,332.22 | -2.9% | +3.5% | -44.0% |